TG THERAPEUTICS, INC. - COMMON STOCK (TGTX)

Historical Holders from Q1 2014 to Q3 2025

Symbol
TGTX on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
158,835,667
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
99,008,750
Holdings value
$3,576,789,165
% of all portfolios
0%
Number of holders
348
Number of buys
148
Number of sells
-180
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 12.8% $883,115,925 20,134,882 BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 10.01% $684,061,613 15,596,480 The Vanguard Group 31 Dec 2024
STATE STREET CORP 5.1% +8% $292,634,861 +$24,085,260 8,100,619 +9% STATE STREET CORPORATION 30 Sep 2025

Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 99,008,750 $3,576,789,165 -$93,569,124 $36.12 348
2025 Q2 101,251,004 $3,644,068,318 +$105,165,687 $35.99 353
2025 Q1 98,398,350 $3,879,797,019 +$91,891,626 $39.43 370
2024 Q4 96,867,606 $2,915,819,583 -$82,204,584 $30.1 325
2024 Q3 101,373,709 $2,371,765,800 -$15,722,787 $23.39 299
2024 Q2 93,092,725 $1,656,135,243 +$59,195,672 $17.79 249
2024 Q1 90,107,125 $1,370,540,354 -$16,725,794 $15.21 234
2023 Q4 90,283,479 $1,542,093,372 +$61,590,148 $17.08 228
2023 Q3 90,485,069 $756,218,410 -$269,126,636 $8.36 230
2023 Q2 88,259,288 $2,192,377,673 -$88,730,550 $24.84 240
2023 Q1 94,743,370 $1,424,911,575 +$49,874,888 $15.04 207
2022 Q4 93,352,835 $1,104,363,051 -$26,457,664 $11.83 194
2022 Q3 98,647,609 $583,969,618 -$39,974,731 $5.92 168
2022 Q2 106,408,531 $452,245,708 -$5,017,128 $4.25 161
2022 Q1 100,868,318 $959,384,130 -$98,040,474 $9.51 169
2021 Q4 100,212,572 $1,902,689,658 +$38,904,536 $19 185
2021 Q3 96,326,356 $3,203,956,013 -$38,579,975 $33.28 213
2021 Q2 96,046,069 $3,725,506,174 -$125,135,262 $38.79 232
2021 Q1 98,807,721 $4,765,076,153 -$16,595,617 $48.2 233
2020 Q4 99,923,648 $5,198,116,671 +$669,912,268 $52.02 246
2020 Q3 87,699,838 $2,345,820,172 +$119,192,436 $26.76 180
2020 Q2 83,924,060 $1,633,423,112 +$391,433,047 $19.48 172
2020 Q1 64,801,021 $638,667,081 +$63,397,220 $9.84 143
2019 Q4 58,195,962 $645,923,679 +$107,765,143 $11.1 132
2019 Q3 48,424,458 $271,901,414 -$14,799,642 $5.62 110
2019 Q2 50,242,483 $434,393,474 +$21,792,679 $8.65 113
2019 Q1 48,122,755 $386,871,816 +$29,442,149 $8.04 108
2018 Q4 48,890,458 $200,441,948 -$49,052 $4.1 108
2018 Q3 47,668,777 $266,945,761 +$31,954,202 $5.6 123
2018 Q2 40,599,564 $533,908,273 +$25,285,157 $13.15 125
2018 Q1 38,595,106 $548,041,984 +$48,773,765 $14.2 120
2017 Q4 35,773,173 $293,344,147 -$8,655,319 $8.2 104
2017 Q3 35,616,666 $422,040,218 +$16,175,615 $11.85 98
2017 Q2 34,343,930 $345,174,620 +$34,148,838 $10.05 104
2017 Q1 30,793,239 $358,729,155 +$141,497,698 $11.65 94
2016 Q4 21,691,451 $100,862,746 -$33,390,293 $4.65 85
2016 Q3 27,043,519 $209,317,474 -$5,208,399 $7.74 70
2016 Q2 27,922,586 $169,210,192 -$14,367,082 $6.06 84
2016 Q1 29,568,032 $251,891,278 +$21,737,929 $8.52 77
2015 Q4 26,883,969 $320,726,141 -$10,358,883 $11.93 86
2015 Q3 28,032,706 $282,560,154 +$33,018,222 $10.08 81
2015 Q2 23,870,474 $396,063,213 +$22,614,129 $16.59 88
2015 Q1 21,468,878 $332,291,565 +$41,921,139 $15.48 79
2014 Q4 18,705,472 $296,099,998 +$46,976,429 $15.84 75
2014 Q3 15,479,378 $165,165,645 +$26,934,922 $10.67 66
2014 Q2 12,980,577 $121,887,208 +$12,525,355 $9.39 65
2014 Q1 11,640,376 $80,287,912 +$31,815,255 $6.9 47